MedPath

Eliem Therapeutics (UK) Ltd.

๐Ÿ‡ฌ๐Ÿ‡งUnited Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

Phase 2
Completed
Conditions
Lumbosacral Radiculopathy
Interventions
Drug: Placebo
First Posted Date
2021-03-03
Last Posted Date
2023-11-07
Lead Sponsor
Eliem Therapeutics (UK) Ltd.
Target Recruit Count
149
Registration Number
NCT04778592
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Delta Clinical Research, Mobile, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Drug Studies America, Marietta, Georgia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Chicago Anesthesia Research Specialist, Chicago, Illinois, United States

and more 21 locations

Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain

Phase 2
Completed
Conditions
Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathy
Interventions
Drug: Placebo
First Posted Date
2020-12-30
Last Posted Date
2023-11-07
Lead Sponsor
Eliem Therapeutics (UK) Ltd.
Target Recruit Count
167
Registration Number
NCT04688671
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Neuro-Pain Medical Cneter, Fresno, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Coral Research Clinic Corp, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Midwest Clinical Research Center, Dayton, Ohio, United States

and more 19 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath